SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances higher full-year revenue guidance, attributed to sustained demand for Amtagvi and Proleukin, is driving attention as traders view it as evidence of commercial growth and improving execution. The reaction is broadly bullish, though some question whether the update is already priced in and look to upcoming lung-cancer data as another catalyst.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQures additional 48-month AMT-130 data for Huntingtons disease is driving attention: cUHDRS slowing weakened versus the 36-month results and did not reach statistical significance, prompting a sharp selloff. Traders debate whether the longer-term results reflect patient dropouts and changes in the external comparator, while bulls argue the FDA-aligned 36-month data remains the basis for the accelerated-approval filing.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

FHFA changes allowing VantageScore alongside FICO in Fannie Mae and Freddie Mac mortgage pricing are fueling concern that competition could weaken FICOs longstanding mortgage-scoring advantage and revenue. Traders are split between viewing the selloff as a lasting threat to the moat and calling it an overreaction, citing FICOs broader software business and continued growth.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

AstraZenecas strategic investment in Summit and clinical collaboration to test ivonescimab in gastrointestinal cancers are driving attention, with traders viewing the deal as financing relief and a strong vote of confidence. Some caution that it is not an acquisition and that the separate FDA decision remains uncertain, while others warn of a possible sell-the-news reaction.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas selection for the U.S. Armys ALATTIS program to develop ultra-high-voltage silicon carbide devices and validate domestic manufacturing is driving attention. Bulls see the award as meaningful technology and government validation, while skeptics note it is a prototype program with no disclosed financial terms or clear near-term revenue; short-squeeze hopes and sell-the-news concerns add to the debate.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

A sharp rebound has fueled breakout chatter, with bullish traders pointing to Zebecs payroll and payments partnershipsincluding MoneyGramas support for its adoption story. Others remain skeptical about weak price follow-through and real-world usage, while speculation about a Robinhood tie-up is unconfirmed.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

AVAXs sharp rally and rising volume have revived breakout talk, with traders pointing to broader altcoin momentum and the tokenization/institutional-adoption narrative, including reported NYSE testing of Avalanche technology. Others doubt the move is supported by lasting demand and warn it could fade as a speculative pump.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Immix reported an 89% complete-response rate in the 45-patient NEXICART-2 update, with all 25 newer patients in complete response or MRD-negative and no relapses or neurotoxicity reported to date. Traders welcomed the clinical results but debated the concurrent registered offering and its potential dilution.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

CROs sharp rebound toward the seven-cent resistance level has fueled breakout talk, with traders pointing to Crypto.coms reported Citadel Securities investment and Cronos app plans as possible tailwinds. Others question whether the move can hold, citing concerns about token supply expansion and Crypto.com leadership.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiaks Phase 3 DAYBREAK results for its experimental wet AMD treatments Zenkuda and KSI-501 are driving attention after both met primary endpoints, fueling a sharp rally and talk of a short squeeze. Traders are divided between optimism about the drugs potential and concerns about valuation, future financing and dilution, FDA approval, and competition from established treatments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zacks.com featured highlights include HF Sinclair, Vince, Ganesco, One Gas and Green Plains

Low-leverage stocks DINO, VNCE, GCO, OGS and GPRE offer financial resilience as macroeconomic uncertainty persists.

5 Low-Leverage Stocks to Buy as US Treasury Yields Cool Down  

These five low-leverage stocks stand out for manageable debt, solid earnings growth and financial resilience as Treasury yields cool.

Oil Prices Remain High, But These 2 Refiners Keep Outperforming

High oil prices haven't slowed Par Pacific and HF Sinclair, as tight fuel supplies and resilient demand keep refining margins strong.

West Coast Refinery Closures Put Nevada's Fuel Supply Under Pressure

West Coast Refinery Closures Put Nevada's Fuel Supply Under Pressure West Coast Refinery Closures Put Nevada's Fuel Supply Under PressurePR NewswireWOODS CROSS, Utah, Sept. 24, 2026 Equity Insider News CommentaryWOODS CROSS, Utah, Sept. 24, 2026 /PRNewswire/ -- The global market for refined...

Here's Why HF Sinclair (DINO) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

5 Low Price-to-Sales Stocks That Deserve Investor Attention

Low price-to-sales stocks can signal value, when supported by solid fundamentals, improving margins and healthy financial strength. PRAA, TPC, DINO, GPRE and PBF stand out.

Will Par Pacific's Retail Expansion Boost Earnings Stability Ahead?

PARR is expanding its retail business through stronger food and merchandise sales, enabling earnings diversification beyond its cyclical refining operations.

Delek vs. HF Sinclair: Which Refining Stock Has More Upside Potential?

DK's strong stock gains, lower valuation and steep EPS estimate revisions highlight key differences with DINO, as both benefit from strong refining markets.

Does HF Sinclair's Diversified Refining Base Enhance Its Resilience?

DINO's diversified refining network and integrated operations position it to benefit from tighter product markets and favorable crack spreads.

HF Sinclair Corporation (DINO) Hit a 52 Week High, Can the Run Continue?

HF Sinclair (DINO) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

HF Sinclair Corp. is an independent energy company. It manufactures and sells products such as gasoline, diesel fuel, jet fuel, renewable diesel, specialty lubricant products, specialty chemicals, and specialty and modified asphalt. The company operates through five segments: Refining, Marketing, Renewables, Lubricants and Specialty Products, and Midstream. The company was founded in 1947 and is headquartered in Dallas, TX.

HF Sinclair Corp.

VLO Stock Heads For Best Year Since 1982 — Michael Burry Says It Has Become A ‘Huge Position’ 

Equity

Bearish Sentiment

Adding risk (buying more)

Trimming/taking profits

Rotating into safer assets

Staying the course, no changes

We&#39;re about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Stocktwits

We're about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Microsoft Corp

Meta Platforms Inc

SELLAS Life Sciences Group Inc

Alphabet Inc Class A

CoreWeave Inc

SpaceX

Stocktwits Polls

HF Sinclair Corporation

$DINO this didn’t dip at all while market was ripping down from $SPY  760 to 750 in the last hour there so will it now die as indexes reverse from the daily bottom and rip possibly higher? Will be watching $USO closely in am and open to see if that gaps down as well

$QQQ $SPCX spaceX really coming back as well wp bulls there

DOOM BOT

$DINO just hit new Ath in ah at 116 when oil only went lower today so can mean one of two things…either oil is expected to catch up and spike more or this could gap down a solid 6-10% short term so I’ll be watching as we approach Friday and why I began covering this today pre maturely waiting to see what this next move will be 

$USO 

$SPY $QQQ

$VIX  we did get a vix spike a bit today like I had mentioned yesterday

$DINO DINO continues to be one of the top ranked momentum stocks because it's got a strong uptrend AND it is a profitable solid company. Also helps that the CEO just bought more shares which raises the score too!

Feed

News

Sentiment

Earnings

Fundamentals

Info

DINO HF Sinclair Corporation

Fundamentals

Latest DINO News